鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/03/28 | 2,221 | 2,221 | 2,190 | 2,203 | -48 | -2.1% | 42,100 |
2019/03/27 | 2,262 | 2,285 | 2,241 | 2,251 | -11 | -0.5% | 55,800 |
2019/03/26 | 2,205 | 2,271 | 2,205 | 2,262 | +59 | +2.7% | 45,700 |
2019/03/25 | 2,210 | 2,258 | 2,200 | 2,203 | -18 | -0.8% | 55,500 |
2019/03/22 | 2,276 | 2,276 | 2,221 | 2,221 | -81 | -3.5% | 64,000 |
2019/03/20 | 2,362 | 2,362 | 2,291 | 2,302 | -60 | -2.5% | 59,300 |
2019/03/19 | 2,382 | 2,398 | 2,356 | 2,362 | -17 | -0.7% | 16,800 |
2019/03/18 | 2,383 | 2,410 | 2,356 | 2,379 | ±0 | ±0% | 48,000 |
2019/03/15 | 2,374 | 2,432 | 2,364 | 2,379 | +22 | +0.9% | 84,600 |
2019/03/14 | 2,317 | 2,465 | 2,316 | 2,357 | +90 | +4% | 201,400 |
2019/03/13 | 2,237 | 2,288 | 2,237 | 2,267 | +2 | +0.1% | 31,400 |
2019/03/12 | 2,201 | 2,275 | 2,201 | 2,265 | +85 | +3.9% | 33,900 |
2019/03/11 | 2,183 | 2,219 | 2,168 | 2,180 | +21 | +1% | 29,400 |
2019/03/08 | 2,202 | 2,223 | 2,152 | 2,159 | -78 | -3.5% | 35,600 |
2019/03/07 | 2,250 | 2,281 | 2,225 | 2,237 | -40 | -1.8% | 33,300 |
2019/03/06 | 2,301 | 2,321 | 2,251 | 2,277 | -38 | -1.6% | 44,700 |
2019/03/05 | 2,330 | 2,345 | 2,306 | 2,315 | -41 | -1.7% | 13,500 |
2019/03/04 | 2,330 | 2,411 | 2,330 | 2,356 | +24 | +1% | 28,000 |
2019/03/01 | 2,319 | 2,364 | 2,319 | 2,332 | +4 | +0.2% | 20,700 |
2019/02/28 | 2,365 | 2,380 | 2,326 | 2,328 | -29 | -1.2% | 34,900 |
2019/02/27 | 2,360 | 2,381 | 2,331 | 2,357 | -12 | -0.5% | 50,200 |
2019/02/26 | 2,375 | 2,386 | 2,340 | 2,369 | -17 | -0.7% | 19,000 |
2019/02/25 | 2,380 | 2,394 | 2,354 | 2,386 | +26 | +1.1% | 27,300 |
2019/02/22 | 2,386 | 2,386 | 2,302 | 2,360 | -32 | -1.3% | 38,700 |
2019/02/21 | 2,437 | 2,446 | 2,357 | 2,392 | +55 | +2.4% | 61,700 |
2019/02/20 | 2,305 | 2,337 | 2,285 | 2,337 | +25 | +1.1% | 24,300 |
2019/02/19 | 2,290 | 2,317 | 2,261 | 2,312 | +55 | +2.4% | 42,300 |
2019/02/18 | 2,230 | 2,292 | 2,230 | 2,257 | +47 | +2.1% | 65,100 |
2019/02/15 | 2,166 | 2,211 | 2,153 | 2,210 | +8 | +0.4% | 29,000 |
2019/02/14 | 2,186 | 2,213 | 2,142 | 2,202 | +2 | +0.1% | 29,600 |
2019/02/13 | 2,235 | 2,235 | 2,182 | 2,200 | -8 | -0.4% | 43,600 |
2019/02/12 | 2,173 | 2,209 | 2,156 | 2,208 | +57 | +2.6% | 65,000 |
2019/02/08 | 2,090 | 2,177 | 2,080 | 2,151 | -4 | -0.2% | 92,600 |
2019/02/07 | 2,225 | 2,235 | 2,132 | 2,155 | -317 | -12.8% | 223,500 |
2019/02/06 | 2,436 | 2,532 | 2,436 | 2,472 | +15 | +0.6% | 50,300 |
2019/02/05 | 2,506 | 2,525 | 2,431 | 2,457 | -49 | -2% | 35,700 |
2019/02/04 | 2,423 | 2,507 | 2,423 | 2,506 | +93 | +3.9% | 27,300 |
2019/02/01 | 2,386 | 2,427 | 2,383 | 2,413 | +14 | +0.6% | 25,800 |
2019/01/31 | 2,392 | 2,413 | 2,388 | 2,399 | +11 | +0.5% | 31,600 |
2019/01/30 | 2,402 | 2,409 | 2,386 | 2,388 | -42 | -1.7% | 65,400 |
2019/01/29 | 2,409 | 2,436 | 2,393 | 2,430 | +21 | +0.9% | 27,800 |
2019/01/28 | 2,448 | 2,449 | 2,402 | 2,409 | -33 | -1.4% | 34,200 |
2019/01/25 | 2,493 | 2,503 | 2,436 | 2,442 | +33 | +1.4% | 51,900 |
2019/01/24 | 2,401 | 2,443 | 2,397 | 2,409 | -8 | -0.3% | 32,500 |
2019/01/23 | 2,453 | 2,460 | 2,400 | 2,417 | -59 | -2.4% | 45,400 |
2019/01/22 | 2,499 | 2,517 | 2,446 | 2,476 | -10 | -0.4% | 24,000 |
2019/01/21 | 2,484 | 2,519 | 2,483 | 2,486 | +15 | +0.6% | 21,000 |
2019/01/18 | 2,467 | 2,507 | 2,467 | 2,471 | +5 | +0.2% | 14,800 |
2019/01/17 | 2,506 | 2,517 | 2,460 | 2,466 | -38 | -1.5% | 33,800 |
2019/01/16 | 2,533 | 2,533 | 2,494 | 2,504 | -18 | -0.7% | 24,900 |
1501~
1550
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム